Q4 2025 Resmed Inc Earnings Call Transcript
Key Points
- ResMed Inc (RMD) reported a strong quarter with a 10% year-over-year revenue growth and a 230 basis points increase in gross margin.
- The company achieved a fiscal year 2025 free cash flow of $1.7 billion, providing significant flexibility for investments and shareholder returns.
- ResMed Inc (RMD) continues to expand its global digital health ecosystem, now serving over 154 million lives through its platforms.
- The company is making strategic acquisitions, such as VirtuOx, to enhance its sleep care funnel and improve patient diagnostics and treatment pathways.
- ResMed Inc (RMD) announced an increase in its quarterly dividend and plans to significantly increase its share repurchase activity in fiscal year 2026.
- The company faces ongoing global macroeconomic uncertainties, including tariffs and trade issues, which could impact operations.
- ResMed Inc (RMD) is navigating a competitive bidding environment in the US, which may affect reimbursement rates and market dynamics.
- There are challenges in scaling home sleep apnea testing, despite strategic acquisitions aimed at improving diagnostics.
- The company is experiencing increased SG&A and R&D expenses, which could pressure margins if not managed effectively.
- ResMed Inc (RMD) is dealing with a complex regulatory landscape, particularly in Washington, Brussels, and Beijing, which requires careful navigation.
Hello and welcome to the Q4 fiscal year 2025 ResMed earnings conference call. My name is Kevin. I'll be your operator for today's call. (Operator Instructions) Also, please note this conference call is being recorded. Later we'll conduct a question and answer session.
Let me hand the call over to Sally Schwartz, ResMed's Chief Investor Relations Officer. Sally, please go ahead.
Thanks, Kevin. I want to welcome our listeners to ResMed's fourth quarter fiscal year 2025 earnings call. We are live webcasting this call from Sydney, and the replay will be available on the Investor Relations section of our corporate website later today.
Our earnings press release and presentation are both available online now. During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for GAAP financial information.
We encourage you to review the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
